Home > Journals > Giornale Italiano di Dermatologia e Venereologia > Past Issues > Giornale Italiano di Dermatologia e Venereologia 2017 December;152(6) > Giornale Italiano di Dermatologia e Venereologia 2017 December;152(6):670-2

CURRENT ISSUE
 

ARTICLE TOOLS

Publication history
Reprints
Cite this article as

GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA

A Journal on Dermatology and Sexually Transmitted Diseases


Official Journal of the Italian Society of Dermatology and Sexually Transmitted Diseases
Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,311


eTOC

 

LETTERS TO THE EDITOR  


Giornale Italiano di Dermatologia e Venereologia 2017 December;152(6):670-2

DOI: 10.23736/S0392-0488.16.05338-4

Copyright © 2016 EDIZIONI MINERVA MEDICA

language: English

Doubling golimumab doses did not improve skin disease in two obese patients with psoriatic arthritis

Claudio BONIFATI , Viviana LORA, Dario GRACEFFA

Center for the Study and Treatment of Psoriasis, San Gallicano Dermatologic Institute for Research and Care, Rome, Italy


PDF  


top of page

Publication History

Issue published online: October 18, 2017
Manuscript accepted: June 20, 2016
Manuscript revised: June 9, 2016
Manuscript received: February 8, 2016

Cite this article as

Bonifati C, Lora V, Graceffa D. Doubling golimumab doses did not improve skin disease in two obese patients with psoriatic arthritis. G Ital Dermatol Venereol 2017;152:670-2. DOI: 10.23736/S0392-0488.16.05338-4

Corresponding author e-mail

psoriasi@ifo.it